MSH Capital Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.18M Buy
10,783
+107
+1% +$31.8K 0.67% 37
2025
Q4
$2.92M Buy
10,676
+31
+0.3% +$8.42K 0.62% 41
2025
Q3
$2.88M Hold
10,645
0.77% 33
2025
Q2
$2.93M Buy
10,645
+97
+0.9% +$26.4K 0.85% 31
2025
Q1
$2.8M Buy
10,548
+15
+0.1% +$3.7K 0.87% 32
2024
Q4
$2.45M Buy
10,533
+2,101
+25% +$483K 0.77% 39
2024
Q3
$1.86M Buy
8,432
+1,041
+14% +$215K 0.57% 56
2024
Q2
$1.45M Buy
7,391
+4,860
+192% +$1M 0.49% 65
2024
Q1
$545K Buy
2,531
+53
+2% +$11.1K 0.19% 125
2023
Q4
$522K Sell
2,478
-300
-11% -$64K 0.2% 121
2023
Q3
$556K Sell
2,778
-134
-5% -$26.6K 0.22% 113
2023
Q2
$540K Buy
+2,912
New +$538K 0.2% 122

Other funds holding CME

MSH Capital Advisors's CME Position: Q1 2026 in Review

MSH Capital Advisors increased its CME Group (CME) stake by 1% in Q1 2026, buying an estimated $31.8K and bringing the position to 10,783 shares worth $3.18M. The position accounts for 0.67% of the portfolio, ranked #37.

MSH Capital Advisors first reported a position in CME in Q2 2023 and has held it in 12 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • MSH Capital Advisors held 10,783 shares of CME Group worth $3.18M as of Q1 2026.
  • MSH Capital Advisors bought 107 CME Group shares in Q1 2026, an estimated $31.8K.
  • CME Group made up 0.67% of MSH Capital Advisors's portfolio in Q1 2026, its #37 holding.
  • MSH Capital Advisors first reported a position in CME Group in Q2 2023 and has held it in 12 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on MSH Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.